4.7 Article

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease

Kenneth I. Ataga et al.

PLOS ONE (2012)

Article Cardiac & Cardiovascular Systems

Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype

A. D. Blann et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)

Review Hematology

β-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability

Kenneth I. Ataga et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects

Joseph A. Jakubowski et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)

Article Hematology

Inflammatory potential of neutrophils detected in sickle cell disease

AFH Lum et al.

AMERICAN JOURNAL OF HEMATOLOGY (2004)

Review Medicine, General & Internal

Hypercoagulability in sickle cell disease: A curious paradox

KI Ataga et al.

AMERICAN JOURNAL OF MEDICINE (2003)

Article Medical Laboratory Technology

Thrombogenesis in sickle cell disease

A Tomer et al.

JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)